Company / Cost of Revenue
LIFECORE BIOMEDICAL, INC. \DE\ Cost of Revenue History
FY2012-FY2019 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cost of Revenue
$390.6M
FY2019
5-year range
$378.9M / $473.9M
FY2015-FY2019
Trend
-4.8%
vs FY2018
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $474M to $391M over the past 2 years.
Based on SEC 10-K filings.
$391M in FY2019 with a 5-year CAGR of +8.0%.
Improved from $474M to $391M over the past 2 years.
Cost of Revenue over time
Growth rates
- 3-Year CAGR
- -1.9%
- 5-Year CAGR
- +8.0%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +8.0%, indicating consistent growth.
- In FY2019, cost of revenue decreased 4.8% year-over-year.
- Peak cost of revenue was recorded in FY2017.
- Lowest cost of revenue in the period was in FY2012.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cost of RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2019 | $390.6M | -4.8% |
| FY2018 | $410.1M | -13.4% |
| FY2017 | $473.9M | +14.4% |
| FY2016 | $414.2M | +9.3% |
| FY2015 | $378.9M | +42.8% |
| FY2014 | $265.4M | +15.4% |
| FY2013 | $230.0M | +12.5% |
| FY2012 | $204.5M | - |
As of FY2019 · SEC 10-K · Updated Jun 24, 2026